Skip to main content
Industry News
Cancer, chemo tied to higher COVID-19 mortality risk

People with cancer had a nearly twofold increased likelihood of dying within 30 days of a COVID-19 diagnosis and those with worsening cancer had a fivefold increased mortality risk, compared with those without cancer, while those with cancer and COVID-19 who received both azithromycin and hydroxychloroquine had a nearly threefold higher odds of mortality, compared with insignificant death risk among those who were given either drug alone, according to a study presented at the American Society of Clinical Oncology's annual meeting and published in The Lancet. Another study presented at the ASCO annual meeting correlated chemotherapy with or without other therapies within three months of a COVID-19 diagnosis with 64% higher mortality risk among patients with thoracic cancers.

Full Story: